We are live on ! Find out more
PCA

Providence Capital Advisors Portfolio holdings

AUM $613M
1-Year Est. Return 17.83%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+17.83%
3 Year Est. Return
+42.1%
5 Year Est. Return
+50.05%
10 Year Est. Return
–
AUM
$408M
AUM Growth
+$45.4M
Cap. Flow
+$36.4M
Cap. Flow %
8.92%
Top 10 Hldgs %
22.24%
Holding
536
New
184
Increased
108
Reduced
56
Closed
65

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$4.5M
2
CSCO icon
Cisco
CSCO
+$4.49M
3
DD icon
DuPont de Nemours
DD
+$4.35M
4
CMCSA icon
Comcast
CMCSA
+$4.29M
5
MDT icon
Medtronic
MDT
+$4.24M

Top Sells

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$4.27M
2
IBM icon
IBM
IBM
+$4.16M
3
BSX icon
Boston Scientific
BSX
+$4.09M
4
MCD icon
McDonald's
MCD
+$4.04M
5
FISV
Fiserv Inc
FISV
+$3.54M

Sector Composition

Rank Sector Weight
1 Technology 18.68%
2 Healthcare 12.58%
3 Financials 10.68%
4 Communication Services 8.67%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KR icon
426
Kroger
KR
$35.1B
$1K ﹤0.01%
18
– –
LPSN icon
427
LivePerson
LPSN
$27.3M
$1K ﹤0.01%
+3
New +$1.21K
OKTA icon
428
Okta
OKTA
$24.9B
$1K ﹤0.01%
+9
New +$1.61K
PHR icon
429
Phreesia
PHR
$706M
$1K ﹤0.01%
+42
New +$1.29K
PLUG icon
430
Plug Power
PLUG
$2.89B
$1K ﹤0.01%
+32
New +$763
PTCT icon
431
PTC Therapeutics
PTCT
$5.91B
$1K ﹤0.01%
+33
New +$1.27K
QTWO icon
432
Q2 Holdings
QTWO
$3.95B
$1K ﹤0.01%
+21
New +$1.35K
RARE icon
433
Ultragenyx Pharmaceutical
RARE
$2.54B
$1K ﹤0.01%
+18
New +$1.25K
RGA icon
434
Reinsurance Group of America
RGA
$15.5B
$1K ﹤0.01%
10
– –
SCS
435
DELISTED
Steelcase
SCS
$1K ﹤0.01%
+117
New +$1.41K
SRPT icon
436
Sarepta Therapeutics
SRPT
$1.77B
$1K ﹤0.01%
+14
New +$1.07K
STAA icon
437
STAAR Surgical
STAA
$1.15B
$1K ﹤0.01%
+15
New +$1.12K
TREX icon
438
Trex
TREX
$4.93B
$1K ﹤0.01%
+21
New +$1.87K
VONG icon
439
Vanguard Russell 1000 Growth ETF
VONG
$44.7B
$1K ﹤0.01%
16
– –
VONV icon
440
Vanguard Russell 1000 Value ETF
VONV
$21B
$1K ﹤0.01%
16
– –
VXRT
441
DELISTED
Vaxart
VXRT
$1K ﹤0.01%
200
– –
WAB icon
442
Wabtec
WAB
$49.9B
$1K ﹤0.01%
10
– –
WEX icon
443
WEX
WEX
$6.46B
$1K ﹤0.01%
+8
New +$1.3K
BERY
444
DELISTED
Berry Global Group, Inc.
BERY
$1K ﹤0.01%
+16
New +$936
AKTS
445
DELISTED
Akoustis Technologies Inc
AKTS
$1K ﹤0.01%
150
– –
SILK
446
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1K ﹤0.01%
+32
New +$1.13K
FSR
447
DELISTED
Fisker Inc.
FSR
$1K ﹤0.01%
100
– –
MRTX
448
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1K ﹤0.01%
+11
New +$1.13K
DEN
449
DELISTED
Denbury Inc.
DEN
$1K ﹤0.01%
+17
New +$1.26K
ABMD
450
DELISTED
Abiomed Inc
ABMD
$1K ﹤0.01%
+4
New +$1.23K
16 17
18
19 20

Similar funds

PSP
Principal Street Partners Memphis, Tennessee $613M AUM 26.72% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
1SAMC
12th Street Asset Management Company Nashville, Tennessee $611M AUM 27.12% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $611M AUM
DTL
Dynamic Technology Lab Singapore $615M AUM 11.3% 1-Year Est. Return
FFWA
FRG Family Wealth Advisors Bellevue, Washington $611M AUM 25.92% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
PL
Pandi LLC Leawood, Kansas $610M AUM 14.97% 1-Year Est. Return

Providence Capital Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Providence Capital Advisors held 536 positions worth $408M, up 13% from $363M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Providence Capital Advisors deployed $36.4M of net new capital in Q1 2022, opening 184 new positions and adding to 108 existing holdings. Its largest new stake was DuPont de Nemours: 44,534 shares worth $4.09M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Dow Inc, an estimated $4.27M trimmed.

  • Providence Capital Advisors's largest Q1 2022 buy was DuPont de Nemours: 44,534 shares worth $4.09M.
  • Providence Capital Advisors added most to Linde in Q1 2022, an estimated $4.5M increase.
  • Providence Capital Advisors's biggest Q1 2022 reduction was Dow Inc, cutting an estimated $4.27M.
  • Providence Capital Advisors fully exited Boston Scientific in Q1 2022, selling an estimated $4.09M.
  • Providence Capital Advisors's ten largest holdings make up 22% of its $408M portfolio in Q1 2022.
  • Providence Capital Advisors opened 184 new positions and closed 65 in Q1 2022.
  • Providence Capital Advisors's portfolio value rose 13% quarter-over-quarter to $408M.

Based on Providence Capital Advisors's 13F filing for Q1 2022, filed 12 May 2022.